Celldex (CLDX) Tops Q3 EPS by 4c

November 7, 2016 4:02 PM

Celldex (NASDAQ: CLDX) reported Q3 EPS of ($0.29), $0.04 better than the analyst estimate of ($0.33). Revenue for the quarter came in at $2.2 million versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.



Next Articles